PDL BioPharma, Inc. Operating Leases, Income Statement, Initial Direct Costs
PDL BioPharma, Inc. reported Operating Leases, Income Statement, Initial Direct Costs of $0 for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesIncomeStatementInitialDirectCosts · last filed 2019-08-07
- PDL BioPharma, Inc. operating leases, income statement, initial direct costs for the quarter ending 2019-06-30 was $0.00.
- PDL BioPharma, Inc. operating leases, income statement, initial direct costs for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- PDL BioPharma, Inc. operating leases, income statement, initial direct costs for the quarter ending 2018-06-30 was $0.00.
- PDL BioPharma, Inc. operating leases, income statement, initial direct costs for the quarter ending 2018-03-31 was $8.00K.
| Period end | Operating Leases, Income Statement, Initial Direct Costs 3 month | Operating Leases, Income Statement, Initial Direct Costs 6 month |
|---|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | $8.00K 10-Q · filed 2019-08-07 |
| 2018-03-31 | $8.00K 10-Q · filed 2019-05-09 |